Therefore, as a future work the designing of leukemia animal models with employing recombinant CXC chemokines CXCL1, CXCL10 and CXCL12 is proposed for the examination of the role and ability of these chemokines in control of AML complications. Here, CXCL10 is linked to acute myeloid leukemia.